Back to AG ADAGE CAPITAL PARTNERS GP, L.L.C.

CYPHCYPH
Showing 1 of 6 quarters

Position history for AGADAGE CAPITAL PARTNERS GP, L.L.C.'s holdings in LEAP THERAPEUTICS INC

No. Adage Capital Partners GP exited its CYPH (Leap Therapeutics) position in Q3 2024. Its Q2 2024 13F listed 113,743 shares worth $222,936. Adage Capital Partners GP first reported CYPH in Q2 2023 and held it in 5 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

$0

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q3
Latest
Exited
0
-100.0%
$00.0%$2.57
0

Other major holders of CYPH: BALYASNY ASSET MANAGEMENT L.P., BAKER BROS. ADVISORS LP, Point72 Asset Management, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used